Roche Holding, Ltd. is a holding company for Roche, a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics.

According to the Complaint, the class seeks injunctive relief to enjoin the consummation of a Tender Offer, announced on February 9, 2009, whereby Roche Holding Ltd, through its wholly-owned subsidiary Roche Investments USA Inc. has commenced a tender offer to acquire the remaining approximately 44% of Genentech's outstanding shares of common stock that it does not already own for $86.50 per share in cash in a transaction valued at approximately $42 billion (the "Tender Offer"). Alternatively, in the event that the Tender Office is completed, Plaintiff seeks to recover damages caused by the breach of fiduciary duties and misleading tender offer materials owed by Defendant to the Company's shareholders.

On July 10, 2009, the Plaintiff, pursuant to Fed. R. Civ. P. Rule 41(a)(1), voluntarily dismissed action with prejudice and without costs.